Premium
PRETREATMENT SOLUBLE INTERLEUKIN‐2 RECEPTOR LEVEL WAS A ROBUST PROGNOSTIC FACTOR IN FOLLICULAR LYMPHOMA IN RITUXIMAB ERA
Author(s) -
Kusano Y.,
Yokoyama M.,
Terui Y.,
Hatake K.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2439_126
Subject(s) - medicine , rituximab , follicular lymphoma , gastroenterology , lymphoma , surgery , median follow up , stage (stratigraphy) , chemotherapy , paleontology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom